Astellas Pharma Inc.

Japan


 
Total IP 1,081
Total IP incl. subs 1,458 (+ 380 for subs)
Total IP Rank # 1,243
IP Activity Score 3.4/5.0    536
IP Activity Rank # 1,339
IP AS incl. subs 3.2/5.0    778
Stock Symbol
ISIN JP3942400007
Market Cap. 3705887172787.5  (JPY)
Industry Drug Manufacturers—General
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

250 78
86 47
469 99
52
 
Last Patent 2025 - Method for producing nonhuman pr...
First Patent 1978 - Cephem and cepham compounds and ...
Last Trademark 2025 - YOUR HEART IN GOOD HANDS
First Trademark 1979 - JOSACINE

Subsidiaries

13 subsidiaries with IP (186 patents, 194 trademarks)

7 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Computer application software for use with web-based platforms and mobile devices in the nature o...
G/S Downloadable computer application software for use with web-based platforms and mobile devices in...
2024 Invention Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer p...
Invention Formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their us...
G/S Pharmaceutical preparations for intraoperative ureter and lymph node visualization for use during...
Invention Training assistance device, training assistance program, training assistance system, and non-tran...
Invention Antibody-drug complex containing toll-like receptor 7/8 dual agonist compound. An antibody-drug ...
Invention Anti-mertk agonist antibody, anti-mertk bispecific antibody, and use thereof. The present inventi...
Invention Antibody-drug conjugate containing heterocyclic compound having activity of inducing decompositio...
Invention Shorts. A pair of shorts comprising: a shorts body (outer fabric, inner fabric); a band-like memb...
Invention Method for producing compound encoded by oligonucleotide, and application thereof. The purpose of...
Invention Selective production of single axially chiral compound. As one embodiment, the present invention ...
Invention Recombinant adeno-associated virus comprising truncated cmv promoter sequence and/or truncated po...
Invention Fc region variant. According to one embodiment, provided is a sialylated Fc region variant compri...
Invention Idez variant. According to one embodiment of the present invention, provided is an IdeZ variant h...
Invention Modified bacteriophage. The present invention provides a bacteriophage having bacteriolytic activ...
Invention Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex. Provi...
Invention Combination therapy involving antibodies against claudin 18.2 for treatment of cancer. The prese...
Invention Pharmaceutical composition comprising a pan-kras degrader. There is provided herein a compound of...
Invention Pharmaceutical composition comprising a quinazoline compound. There is provided herein compounds ...
Invention Cell penetrating peptide. An object of the present invention is to provide a cell penetrating pe...
Invention Method for producing type 2 innate lymphocytes. The present invention addresses the problem of es...
Invention Antibodies against claudin 18.2 useful in cancer diagnosis. The invention relates to antibodies ...
Invention Pharmaceutical composition for modified release. A pharmaceutical composition for modified releas...
G/S Providing medical information
Invention Terminal apparatus, game execution method, program, and server. This terminal apparatus is for ex...
Invention Cell sowing method. The present invention relates to a cell sowing method and a cell culture meth...
G/S incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
G/S Provision of incubation services, namely, arranging of business resources and/or finance for busi...
Invention Carbamoyl lipid or urea lipid each having cyclic amine, lipid nanoparticles containing same, and ...
Invention Antibodies useful in cancer diagnosis. The invention relates to antibodies directed against an e...
2023 Invention Engineered natural killer cells and related methods. The disclosure provides a population of engi...
Invention 4-aminopiperidine compound, lipid nanoparticles thereof, and pharmaceutical composition containin...
Invention Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant p...
G/S Pharmaceutical product for the treatment of cancer.
G/S Pharmaceutical product for the treatment of cancer.
G/S Pharmaceutical product for the treatment of cancer
G/S provision of incubation services, namely, arranging of business resources and/or finance for busi...
G/S Incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
G/S Business administration of health reimbursement arrangements; providing business information rega...
Invention Method for selective production of single axially chiral compound. Problem: When a compound havin...
Invention Method for producing nonhuman primate animal model of cerebral infarction and pharmaceutical comp...
Invention Azacycloalkyl carbonyl cyclic amine compound. Provided is an azacycloalkyl carbonyl cyclic amine ...
G/S Pharmaceutical products for the treatment of cancer.
G/S Pharmaceutical preparations for the treatment of cancer.
G/S Pharmaceutical preparations for the treatment of cancer
G/S Pharmaceutical preparations for the treatment of cancer
Invention Heterocyclic compound for inducing degradation of g12d mutant kras protein. To provide a compound...
G/S Downloadable medical software for processing and displaying images on ultrasound medical imaging ...
G/S Pharmaceutical preparations. Software for medical purposes; computer programs; telecommunication ...
G/S Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bla...
2022 Invention Substituted quinoline derivative. The present inventors have studied and found that the substitu...
Invention Pharmaceutical composition comprising a quinazoline compound. The present invention has an objec...
Invention Indocyanine compound-containing solid pharmaceutical composition. Provided is a stable solid pha...
Invention Agents for treatment of claudin expressing cancer diseases. The present invention provides bindi...
G/S Pharmaceutical preparation for the treatment of cancer and for gastrointestinal disorders and dis...
G/S Pharmaceutical product for the treatment of cancer and for gastro-intestinal disorders and disea...
G/S Pharmaceutical product for the treatment of cancer and for gastro-intestinal disorders and diseas...
G/S Pharmaceutical preparations for the treatment of cancer and for gastro-intestinal disorders and d...
G/S Pharmaceutical products for the treatment of cancer and for gastro-intestinal disorders and disea...
Invention A pharmaceutical composition for imaging. Intraoperative ureter identification helps reduce the ...
Invention Vascular endothelial growth factor (vegf)-highly expressing pericyte-like cell. An object of the...
Invention Method for producing vascular endothelial growth factor (vegf)- highly expressing pericyte-like c...
G/S Pharmaceutical preparations for the treatment of cancer, cardiovascular, and urological diseases ...
Invention Methods of use of ppar agonist compounds and pharmaceutical compositions thereof. The present di...
Invention Machine learning methods to predict menopause symptoms and treatment options. Techniques are pro...
Invention Substituted triazine compound. An object of the present invention is to provide a pharmaceutical...
Invention Anti-cldn4/anti-cd137 bispecific antibody. An object of the present invention is to provide an an...
Invention Composition for contrast imaging of cancer. An object of the present invention is to provide a c...
Invention Combination of talazoparib and an anti-androgen for the treatment of ddr gene mutated metastatic ...
Invention Pericyte having basic fibroblast growth factor (bfgf) gene introduced therein. An object of the ...
Invention Quinazoline compound for inducing degradation of g12d mutant kras protein. [Problem] To provide ...